(Q35779249)

10 August 2017

1 reference

title

Novel pharmacological therapies for the treatment of AIDS-related Kaposi's sarcoma (English)

1 reference

AIDS-related Kaposi's sarcoma

10 August 2017

main subject

1 reference

Anna Maria Cattelan

1

1 reference

10 August 2017

Marco Trevenzoli

series ordinal

2

1 reference

10 August 2017

Savina Maria Lucia Aversa

series ordinal

3

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 May 2004

1 reference

Expert Opinion on Investigational Drugs

10 August 2017

published in

1 reference

10 August 2017

volume

13

1 reference

10 August 2017

issue

5

1 reference

10 August 2017

page(s)

501-513

1 reference

Idiopathisches multiples Pigmentsarkom der Haut

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.5.501

Kaposi's sarcoma in mainland Tanzania: a report of 117 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.5.501

Kaposi's Sarcoma in Uganda: Geographic and Ethnic Distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.5.501

The appearance of Kaposi sarcoma during corticosteroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.5.501

Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.5.501

The epidemiology of AIDS--related neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.5.501

Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.5.501

Malignant tumors and AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.5.501

HIV infection and neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.5.501

Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.5.501

The role of radiation therapy in the management of HIV-related Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.5.501

The antiviral drug docosanol as a treatment for Kaposi's sarcoma lesions in HIV type 1-infected patients: a pilot clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.5.501

Recombinant human interferon alfa-A suppresses HTLV-III replication in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.5.501

Antiretroviral therapy in combination with interferon for AIDS-related Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.5.501

Interferon-alpha with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.5.501

Prospective randomized trial of two dose levels of interferon alfa with zidovudine for the treatment of Kaposi's sarcoma associated with human immunodeficiency virus infection: a Canadian HIV Clinical Trials Network study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.5.501

Vinblastine therapy for Kaposi's sarcoma in the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.5.501

Treatment of Kaposi's sarcoma and thrombocytopenia with vincristine in patients with the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.5.501

Clinical and pharmacokinetic study of oral etoposide in patients with AIDS-related Kaposi's sarcoma with no prior exposure to cytotoxic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.5.501

Polyethylene glycol-liposomal doxorubicin: a review of its use in the management of solid and haematological malignancies and AIDS-related Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.5.501

Potentiation of cytotoxicity of Kaposi's sarcoma related to immunodeficiency syndrome (AIDS) by liposome-encapsulated doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.5.501

Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.5.501

Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.5.501

Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi sarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.5.501

Paclitaxel for anthracycline-resistant AIDS-related Kaposi's sarcoma: clinical and angiogenic correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.5.501

Phase II evaluation of low-dose oral etoposide for the treatment of relapsed or progressive AIDS-related Kaposi's sarcoma: an AIDS Clinical Trials Group clinical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.5.501

Clearance of HHV-8 from peripheral blood mononuclear cells with a protease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.5.501

Complete remission of AIDS/Kaposi's sarcoma after treatment with a combination of two nucleoside reverse transcriptase inhibitors and one non-nucleoside reverse transcriptase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.5.501

Highly active anti-retroviral therapy (HAART) prolongs time to treatment failure in Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.5.501

Prospective study of the effects of antiretroviral therapy on Kaposi sarcoma--associated herpesvirus infection in patients with and without Kaposi sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.5.501

Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.5.501

In vitro antiviral drug sensitivity of the Kaposi's sarcoma-associated herpesvirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.5.501

Effect of antiviral drugs used to treat cytomegalovirus end-organ disease on subsequent course of previously diagnosed Kaposi's sarcoma in patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.5.501

Cell cycle inhibition by the anti-angiogenic agent TNP-470 is mediated by p53 and p21WAF1/CIP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.5.501

Thalidomide is an inhibitor of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.5.501

Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8+ subset

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.5.501

Results of a randomized study of IM862 nasal solution in the treatment of AIDS-related Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.5.501

Antiproliferative effect of retinoid compounds on Kaposi's sarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.5.501

Antitumor activity of oral 9-cis-retinoic acid in HIV-associated Kaposi's sarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.5.501

9-cis-retinoic acid capsules in the treatment of AIDS-related Kaposi sarcoma: results of a phase 2 multicenter clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.5.501

Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.5.501

The effects of preparations of human chorionic gonadotropin on AIDS-related Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.5.501

Phase I study of human chorionic gonadotropin given subcutaneously to patients with acquired immunodeficiency syndrome-related mucocutaneous Kaposi's sarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.5.501

Highly active antiretroviral therapy in AIDS-associated Kaposi's sarcoma: implications for the design of therapeutic trials in patients with advanced, symptomatic Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.5.501

Activity of thalidomide in AIDS-related Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.5.501

10.1517/13543784.13.5.501

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference